Main menu

Oxford Nanopore announces £109.5M ($144.5M) in investment and share sales


2 January 2020, Oxford, UK: Oxford Nanopore Technologies has raised £29.3M ($38.6M) in new capital and additionally facilitated the sale of £80.2M ($105.9) in secondary shares, resulting in total gross proceeds of £109.5M ($144.5M).

These funds have been raised internationally and include both new investors and existing shareholders, from the US, Europe and Asia/Pacific.

This brings the total primary investment in Oxford Nanopore to ~£480M to date.

Further information on Oxford Nanopore’s fundraising will be made available in due course.

The Company made substantial progress in 2019; from scaling up to population-scale sequencing with PromethION, to accurate, rapid testing in cancer and infectious disease.; Read 19 highlights of 2019.

USD amounts assume exchange rate of 1.32 at 31st December 2019.

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms, conditions and policies Accessibility

About Oxford Nanopore

Contact us News Media resources & contacts Investor centre Careers BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Spanish flag